ENAH and marginal zone lymphoma: Although the number of cases for specific subtypes was small, a positive test for at least one other autoantibody (anti-ENA or anti-dsDNA) was associated with a significantly increased risk of developing DLBCL or MZL compared to those who tested negative (OR: 3.51, 95% CI: 1.02–12.0, p = 0.046 and OR: 8.86, 95% CI: 1.26–62.0, p = 0.015, respectively).